
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
Description
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
The Oncology Precision Medicine Market size was estimated at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030.
Global Oncology Precision Medicine Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Oncology Precision Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oncology Precision Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Oncology Precision Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AstraZeneca PLC, B. J. Madan & Co., Bayer AG, Bristol-Myers Squibb Company, Cepheid Inc., Eli Lilly & Company, F. Hoffmann-La Roche Ltd, Genome Medical boasts, GSK PLC, IQVIA Inc., Laboratory Corporation of America Holding, llumina, Inc., Merck KGaA, Novartis AG, OneOme, LLC, Pfizer Inc., Rain Oncology Inc., Relay Therapeutics, Sanofi S.A., Strata Oncology, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., Variantyx, Inc., and Xilis, Inc..
Market Segmentation & Coverage
This research report categorizes the Oncology Precision Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Cell & Gene Therapy
Inhibitor drugs
Monoclonal Antibodies
Cancer Type
Breast Cancer
Cervical Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
End-use
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Oncology Precision Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oncology Precision Medicine Market?
3. What are the technology trends and regulatory frameworks in the Oncology Precision Medicine Market?
4. What is the market share of the leading vendors in the Oncology Precision Medicine Market?
5. Which modes and strategic moves are suitable for entering the Oncology Precision Medicine Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Oncology Precision Medicine Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidence of cancer among the global population
- 5.1.1.2. Government initiatives to promote precision medicine
- 5.1.1.3. Increasing adoption of genetic testing to enhance precision medicine
- 5.1.2. Restraints
- 5.1.2.1. Limited reimbursement available for oncology precision medicine treatment
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing R&D to develop personalized medicine to treat cancer
- 5.1.3.2. Advances in clinical next-generation sequencing for tumor tissue and liquid biopsy
- 5.1.4. Challenges
- 5.1.4.1. Complex regulatory framework surrounding precision oncology
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Oncology Precision Medicine Market, by Type
- 6.1. Introduction
- 6.2. Cell & Gene Therapy
- 6.3. Inhibitor drugs
- 6.4. Monoclonal Antibodies
- 7. Oncology Precision Medicine Market, by Cancer Type
- 7.1. Introduction
- 7.2. Breast Cancer
- 7.3. Cervical Cancer
- 7.4. Colorectal Cancer
- 7.5. Lung Cancer
- 7.6. Prostate Cancer
- 8. Oncology Precision Medicine Market, by End-use
- 8.1. Introduction
- 8.2. Hospitals & Diagnostic Laboratories
- 8.3. Pharmaceutical & Biotechnology Companies
- 9. Americas Oncology Precision Medicine Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Oncology Precision Medicine Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Oncology Precision Medicine Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AbbVie Inc.
- 13.1.2. AstraZeneca PLC
- 13.1.3. B. J. Madan & Co.
- 13.1.4. Bayer AG
- 13.1.5. Bristol-Myers Squibb Company
- 13.1.6. Cepheid Inc.
- 13.1.7. Eli Lilly & Company
- 13.1.8. F. Hoffmann-La Roche Ltd
- 13.1.9. Genome Medical boasts
- 13.1.10. GSK PLC
- 13.1.11. IQVIA Inc.
- 13.1.12. Laboratory Corporation of America Holding
- 13.1.13. llumina, Inc.
- 13.1.14. Merck KGaA
- 13.1.15. Novartis AG
- 13.1.16. OneOme, LLC
- 13.1.17. Pfizer Inc.
- 13.1.18. Rain Oncology Inc.
- 13.1.19. Relay Therapeutics
- 13.1.20. Sanofi S.A.
- 13.1.21. Strata Oncology, Inc.
- 13.1.22. Takeda Pharmaceutical Company Limited
- 13.1.23. Thermo Fisher Scientific, Inc.
- 13.1.24. Variantyx, Inc.
- 13.1.25. Xilis, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ONCOLOGY PRECISION MEDICINE MARKET RESEARCH PROCESS
- FIGURE 2. ONCOLOGY PRECISION MEDICINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. ONCOLOGY PRECISION MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ONCOLOGY PRECISION MEDICINE MARKET DYNAMICS
- FIGURE 7. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
- FIGURE 10. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 12. ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY PRECISION MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ONCOLOGY PRECISION MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ONCOLOGY PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.